US Patent 7563885 Modulation of Tudor-SN expression

Patent 7563885 was granted and assigned to Ionis Pharmaceuticals on July, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ionis Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7563885

Date of Patent

July 21, 2009

Patent Application Number

11135255

Date Filed

May 23, 2005

Patent Primary Examiner

‌

Brian Whiteman

Patent abstract

Compounds, compositions and methods are provided for modulating the expression of Tudor-SN. The compositions comprise oligonucleotides, targeted to nucleic acid encoding Tudor-SN. Methods of using these compounds for modulation of Tudor-SN expression and for diagnosis and treatment of diseases and conditions associated with expression of Tudor-SN are provided.